Tolperisone Hydrochloride

DRUG3 trials

Sponsors

Neurana Pharmaceuticals, Inc., Semmelweis University

Conditions

Acute PainBack Muscle SpasmBack PainBack Spasm UpperBack StrainHealthyLow Back PainMuscle Spasm

Phase 1

Effects of Tolperisone on Measures of Drowsiness and Cognitive Function

CompletedNCT04407377

Neurana Pharmaceuticals, Inc.Healthy

Start: 2020-06-20End: 2021-03-31Updated: 2022-02-01

Phase 3

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm

CompletedNCT04671082

Neurana Pharmaceuticals, Inc.Acute Pain, Back Muscle Spasm, Back Pain +3

Start: 2020-12-15End: 2022-03-21Updated: 2022-03-22

The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain BETA

Active, not recruitingNCT05544656

Semmelweis UniversityLow Back Pain

Start: 2019-12-13End: 2024-06-30Target: 150Updated: 2024-04-17

Related Papers

RESUME-1: A Phase III Study of Tolperisone in the Treatment of Painful, Acute Muscle Spasms of the Back

Pain Management2021-07-0110 citations